Provided by Tiger Fintech (Singapore) Pte. Ltd.

NEWAMSTERDAM PHARMA CO NV

18.55
+0.72004.04%
Pre-market: 18.910.3600+1.94%09:15 EDT
Volume:424.05K
Turnover:7.75M
Market Cap:2.04B
PE:-7.24
High:18.62
Open:17.80
Low:17.43
Close:17.83
Loading ...
Nov 18, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2024

Major Issues Report

Form 8-K - Current report
Oct 28, 2024

[Rev.]Annual Report

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
Oct 19, 2024

Correspondence

Form CORRESP - Correspondence
Oct 18, 2024

Major Issues Report

Form 8-K - Current report
Oct 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 23, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 09, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

Correspondence

Form CORRESP - Correspondence
Aug 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2024

Major Issues Report

Form 8-K - Current report
Jul 29, 2024

Major Issues Report

Form 8-K - Current report
Jul 18, 2024

Major Issues Report

Form 8-K - Current report
Jul 09, 2024

Correspondence

Form CORRESP - Correspondence
Jul 04, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 11, 2024

Major Issues Report

Form 8-K - Current report